NCT03438981View on ClinicalTrials.gov

Optimization of PK/PD Target Attainment for Ceftriaxone in Critically Ill Patients With Community-acquired Pneumonia.

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

July 31, 2019

Conditions
PharmacokineticsCritical Illness
Trial Locations (1)

3000

UZLeuven, Leuven

All Listed Sponsors
collaborator

KU Leuven

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03438981 - Optimization of PK/PD Target Attainment for Ceftriaxone in Critically Ill Patients With Community-acquired Pneumonia. | Biotech Hunter | Biotech Hunter